Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1)

Molecular and Cellular Biology

Volumn 17, Issue 7, 1997, Pages 3850-3857

  Aktas, Huseyin ^a   Cai, Hong ^a   Cooper, Geoffrey M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL GROWTH; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030989155     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.7.3850     Document Type: Article

References (52)

1. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
2. Arber, N., T. Sutter, M. Miyake, S. M. Kahn, V. S. Venkatraj, A. Sobrino, D. Warburton, P. R. Holt, and I. B. Weinstein. 1996. Increased expression of cyclin D1 and the RB tumor suppressor gene in c-K-ras transformed rat enterocytes. Oncogene 12:1903-1908.
3. 1. Genes Dev. 7:812-821.
4. Cai, H., P. Erhardt, J. Troppmair, M. T. Diaz-Meco, G. Sithanandam, U. R. Rapp, J. Moscat, and G. M. Cooper. 1993. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol. Cell. Biol. 13:7645-7651.
5. Cai, H., J. Szeberenyi, and G. M. Cooper. 1990. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells. Mol. Cell. Biol. 10:5314-5323.
6. 1 phase in BALB/c 3T3 cells. Mol. Cell. Biol. 14:5441-5449.
7. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
8. 2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 66:731-742.
9. Feig, L. A., and G. M. Cooper. 1988. Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol. Cell. Biol. 8:3235-3243.
10. Furth, M. E., L. J. Davis, B. Fleurdelys, and E. M. Scolnick. 1982. Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43:294-304.
11. Gu, Y., C. W. Turck, and D.O.Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
12. INK4B is a potential effector of TGF-β induced cell cycle arrest. Nature 371:257-261.
13. 1 cyclin-dependent kinases. Cell 75:805-816.
14. Kip1 accumulation during the cell cycle. Science 271:1861-1864.
15. 1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol. 16:2402-2407.
16. Hirai, H., M. F. Roussel, J.-Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15:2672-2681.
17. Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496.
18. Kolch, W., G. Heidecker, P. Lloyd, and U. R. Rapp. 1991. Raf-1 protein kinase is required for growth of induced NIH/3T3 cells. Nature 349:426-428.
19. MAPK pathway. J. Biol. Chem. 271:20608-20616.
20. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
21. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
22. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
23. Marshall, C. J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
24. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
25. PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
26. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
27. 1 phase of the cell cycle. Cell 65:701-713.
28. Meyerson, M., and E. Harlow. 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
29. Mulcahy, L. S., M. R. Smith, and D. W. Stacey. 1985. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313:241-243.
30. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
31. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
32. Pagano, M., S. W. Tam, A. M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685.
33. 1 events and regulation of cell proliferation. Science 246:603-608.
34. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
35. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
36. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
37. KIP1. Mol. Cell. Biol. 15:4347-4352.
38. Reynisdottir, I., K. Polyak, A. Iavarone, and J. Massague. 1995. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 9:1831-1845.
39. Sebastian, B., A. Kakizuka, and T. Hunter. 1993. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA 90:3521-3524.
40. 1 phase progression: cycling on cue. Cell 79:551-555.
41. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
42. Slingerland, J. M., L. Hengst, C.-H. Pan, D. Alexander, M. R. Stampfer, and S. I. Reed. 1994. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol. 14:3683-3694.
43. 1 cyclin-cdk complexes. EMBO J. 14:4814-4826.
44. Surmacz, E., K. Reiss, C. Sell, and R. Baserga. 1992. Cyclin D1 messenger RNA is inducible by platelet-derived growth factor in cultured fibroblasts. Cancer Res. 52:4522-4525.
45. Temin, H. M. 1971. Stimulation by serum of multiplication of stationary chicken cells. Cell. Physiol. 78:161-170.
46. 1 arrest induced by ultraviolet irradiation. Nature 376:358-362.
47. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
48. Tsai, L.-H., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8:1593-1602.
49. Van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dcpendent kinases in cell cycle control. Science 262:2050-2054.
50. Winston, J. T., S. R. Coats, Y.-Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
51. Won, K. A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910-9914.
52. Xiong, Y., G. J. Hannon, H. Zang, D. Casso, R. Kobayasi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.